Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Renuka Ramnath resigns from Fortis expert panel

      Renuka Ramnath resigns from Fortis expert panel

      Ruby Khatun Khatun26 April 2018 10:14 AM IST
      New Delhi: Fortis Healthcare said Renuka Ramnath, former MD, and CEO of ICICI Venture, has resigned from the expert committee set by the healthcare...
      Medicare will require hospitals to post prices online

      Medicare will require hospitals to post prices online

      Ruby Khatun Khatun26 April 2018 10:00 AM IST
      WASHINGTON: Medicare says it plans to require hospitals to post their standard prices online and to make electronic medical records more readily...
      Johnson and Johnson wins appeal to overturn 151 million dollar hip implant verdict

      Johnson and Johnson wins appeal to overturn 151 million dollar hip implant verdict

      Ruby Khatun Khatun26 April 2018 9:45 AM IST
      Johnson and Johnson secured a favorable U.S. appellate court ruling, overturning a verdict that had awarded $151 million to five people who blamed...
      AstraZeneca flop a fresh blow to cancer immunotherapy combination

      AstraZeneca flop a fresh blow to cancer immunotherapy combination

      Ruby Khatun Khatun26 April 2018 9:30 AM IST
      LONDON: The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has...
      Fortis Update: Investors pile up with revised Offers

      Fortis Update: Investors pile up with revised Offers

      Ruby Khatun Khatun25 April 2018 4:44 PM IST
      New Delhi: The race to acquire Fortis healthcare is getting steamier with many of its present bidders revising their offers before the Fortis...
      Dr Reddys gets EIR from USFDA for UK plant

      Dr Reddy's gets EIR from USFDA for UK plant

      Ruby Khatun Khatun25 April 2018 10:30 AM IST
      New Delhi: Dr Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator after audit of its UK...
      SRL Diagnostics looks to double its retail presence in Kolkata

      SRL Diagnostics looks to double its retail presence in Kolkata

      Ruby Khatun Khatun25 April 2018 10:15 AM IST
      Kolkata: SRL Diagnostics, India's largest and most trusted diagnostics chain, will nearly double its owned Pathology Center network in Kolkata, over...
      Merck Foundation and Tata Memorial Centre signs MoU to build cancer care capacity in Africa

      Merck Foundation and Tata Memorial Centre signs MoU to build cancer care capacity in Africa

      Ruby Khatun Khatun25 April 2018 10:00 AM IST
      Mumbai: Merck Foundation, the philanthropic arm of Merck KGaA Germany, and the Tata Memorial centre, a premier cancer center in India, announced the...
      UK bans Sanofi epilepsy drug without pregnancy prevention plan

      UK bans Sanofi epilepsy drug without pregnancy prevention plan

      Ruby Khatun Khatun25 April 2018 9:45 AM IST
      LONDON: A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of...
      Express Scripts targets Amgen, Lilly migraine drugs in pricing shift

      Express Scripts targets Amgen, Lilly migraine drugs in pricing shift

      Ruby Khatun Khatun25 April 2018 9:30 AM IST
      LOS ANGELES: The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen...
      Munjals, Burmans extend validity of their offer for Fortis till May 4

      Munjals, Burmans extend validity of their offer for Fortis till May 4

      Ruby Khatun Khatun24 April 2018 10:45 AM IST
      New Delhi: Fortis Healthcare said Hero Enterprise Investment and the Burman Family have extended the validity of their improved, joint binding offer...
      Lupin gets USFDA nod to market Tetrabenazine tablets

      Lupin gets USFDA nod to market Tetrabenazine tablets

      Ruby Khatun Khatun24 April 2018 10:15 AM IST
      New Delhi: Drug firm Lupin said it has received approval from the US health regulator to market in America its Tetrabenazine tablets used for the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok